Abetimus
Abetimus Uses, Dosage, Side Effects, Food Interaction and all others data.
Abetimus was developed by La Jolla Pharmaceuticals as an immunosuppressant but was never marketed in American or Europe despite application for marketing authorization in the mid-2000s.
Trade Name | Abetimus |
Generic | Abetimus |
Abetimus Other Names | Abetimus |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in kidney disease and systemic lupus erythematosus.
Innovators Monograph
You find simplified version here Abetimus